Cargando…
Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
Olanzapine is an atypical antipsychotic drug that is clinically applied in patients with schizophrenia. It increases the risk of dyslipidemia, a disturbance of lipid metabolic homeostasis, usually characterized by increased low-density lipoprotein (LDL) cholesterol and triglycerides, and accompanied...
Autores principales: | Zhou, Zijian, Nagashima, Takuya, Toda, Chihiro, Kobayashi, Mone, Suzuki, Takahide, Nagayasu, Kazuki, Shirakawa, Hisashi, Asai, Satoshi, Kaneko, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989177/ https://www.ncbi.nlm.nih.gov/pubmed/36895943 http://dx.doi.org/10.3389/fphar.2023.1135516 |
Ejemplares similares
-
Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data
por: Yamamoto, Hiroki, et al.
Publicado: (2023) -
Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway
por: Nozawa, Keisuke, et al.
Publicado: (2023) -
Increased expression of glutathione peroxidase 3 prevents tendinopathy by suppressing oxidative stress
por: Furuta, Haruka, et al.
Publicado: (2023) -
Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism
por: Nagashima, Takuya, et al.
Publicado: (2016) -
Striatal TRPV1 activation by acetaminophen ameliorates dopamine D(2) receptor antagonist–induced orofacial dyskinesia
por: Nagaoka, Koki, et al.
Publicado: (2021)